New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 15 states.

Cannabis sales decreased 4.3% sequentially in September, which was a decrease on a per-day basis of 1.1%. In this review, we share the results by state, beginning with the western markets and then concluding with the eastern markets. In total, BDSA estimates that sales across the 15 markets totaled $2.06 billion during September, which was up 7.1% from a year ago. Excluding the large gain in New York, which I explain below, sales rose 1.2%. Note that BDSA revised Florida and Pennsylvania data historically.

Western Markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In September, year-over-year growth was negative in 3 states. Growth fell sequentially on a per-day basis in three of these states.

Eastern Markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. In September, year-over-year growth ranged from -4.9% in New Jersey to +945.9% in New York, which had its adult-use sales included by BDSA beginning in January but first included a few months ago. Ohio began adult-use in August which has boosted the growth. Note that Florida and Pennsylvania are medical-only markets. Sequential growth was flat in two markets and negative eight markets and fell in these three markets on a per-day basis.  The annual growth was meager except in two states. We have been warning about Florida potentially slowing despite the strong growth in dispensaries and in unit volumes due to competitive pressure, and it fell slightly a year ago after an annual decline in April earlier this year.

For readers interested in a deeper look at cannabis markets across these fifteen states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with access to actionable data and analysis.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email